We provide you with 20 years of free, institutional-grade data for SCPS stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SCPS. Explore the full financial landscape of SCPS stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about SCPS stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Scopus BioPharma Inc(NASDAQ:SCPS) 
Scopus BioPharma Inc., a biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. Its lead development programs are immuno-oncology gene therapy for the treatment of various cancers, which include CO-sTiRNA, a STAT3 inhibitor gene therapy that drives...
Website: https://scopusbiopharma.com/
Founded: 2017
Full Time Employees: 1 (May 2021)
CEO: Joshua R. Lamstein
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends